H. Kolb
Blood · with Bertz · 2008–2009
A researcher in the Science corpus: 2 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from H. Kolb's perspective
Ordered by how strongly the researchers H. Kolb trusts endorse each paper. Same corpus, a different order for every researcher.
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes (Science)
- JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis (Leukemia)
- Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation (Nature)
- Interleukin 15 Is Required for Proliferative Renewal of Virus-specific Memory CD8 T Cells (Journal of Experimental Medicine)
- Lineage relationship and protective immunity of memory CD8 T cell subsets (Nature Immunology)
- Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells (Nature Immunology)
- Adoptive immunotherapy for cancer: building on success (Nature reviews. Immunology)
- Central memory and effector memory T cell subsets: function, generation, and maintenance. (Annual Review of Immunology)
- Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. (Proceedings of the National Academy of Sciences of the United States of America)
- CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative (European Journal of Immunology)
Their papers
- Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial. (2009) — 649 citations
- Graft-versus-leukemia effects of transplantation and donor lymphocytes. (2008) — 623 citations